Authors: Mark I Travin
Publish Date: 2016/07/14
Volume: 24, Issue: 1, Pages: 239-244
Abstract
Molecular imaging with radiotracers provides unique ability to assess the potential for lethal ventricular tachyarrhythmias and sudden cardiac death SCD from them and has shown promise to become an effective tool for management of patients at risk in a manner complementary to and in some cases better than routine clinical evaluation and alternative imaging modalities1Ventricular tachyarrhythmias can occur in almost all cardiac diseases and are generally associated with increased risk However arrhythmias are often not a direct threat but instead reflect disease severity and therefore do not require specific treatment Therapeutic intervention should be limited to symptomatic patients or those determined to be specifically at risk for SCD either because of a previous event such as a resuscitated cardiopulmonary arrest secondary prevention or based on patient findings that a fatal arrhythmic event has a significant likelihood of occurring in the foreseeable future primary
Keywords: